Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study [0.03%]
利益相关者视角下的患者参与数字化依从性技术的研发和实施研究
Dalma Hosszú,Alexandra L Dima,Francisca Leiva Fernández et al.
Dalma Hosszú et al.
Background: This study aims to create a comprehensive framework for the development and implementation of digital medication adherence technologies (DMATech), focusing on critical stages where engagement of medication use...
How can physicians improve medication adherence and outcomes in dermatological conditions? [0.03%]
医师如何改善皮肤病患者的药物顺应性及治疗效果？
Jessica Q Duong,Ryan F Bloomquist,Steven R Feldman
Jessica Q Duong
Introduction: Medication non-adherence is a major contributor to suboptimal disease treatment across medical specialties and is a particular hurdle with topicals. While adherence is a patient behavior affected by many soc...
Wolf Rogowski
Wolf Rogowski
Introduction: Health economic evaluation (HEE) provides guidance for decision-making in the face of scarcity but ignores ecological scarcities as long as they involve external costs only. Following the imperative to accou...
Preferences of people with diabetes for diabetes care in Germany: a discrete choice experiment [0.03%]
德国糖尿病患者的糖尿病护理偏好：一种离散选择实验分析
Markus Vomhof,Anna C Boersma,Dorijn F L Hertroijs et al.
Markus Vomhof et al.
Objectives: The objective of this study is to elicit health care preferences of people with diabetes and identify classes of people with different preferences. ...
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services [0.03%]
综合依从性干预在骨折联络服务中的成本效益分析
Lieke Maas,Annelies Boonen,Nannan Li et al.
Lieke Maas et al.
Background: This study aims to assess the lifetime cost-effectiveness of a multi-component adherence intervention (MCAI), including a patient decision aid and motivational interviewing, compared to usual care in patients ...
Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines - a case study of oncology drugs [0.03%]
药品创新指数——以肿瘤药物为例的评估方法学研究
Ludmila P Gargano,Juliana Alvares-Teodoro,Francisco de A Acurcio et al.
Ludmila P Gargano et al.
Background: We propose a framework to assess the value of pharmaceutical innovations, with explicit clinical and methodological parameters, based on the therapeutic value and health needs. ...
A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United Kingdom [0.03%]
平衡预算下英国季节性和大流行性流感患者使用玛巴洛沙韦与奥司他韦或不用药的成本效益分析
Svenn Alexander Kommandantvold,Annabelle Lemenuel-Diot,Chris Skedgel et al.
Svenn Alexander Kommandantvold et al.
Background: Baloxavir marboxil is an oral, single-dose, cap-dependent endonuclease inhibitor that reduces the duration of influenza symptoms and rapidly stops viral shedding. We developed a susceptible, exposed, infected,...
Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective [0.03%]
从意大利国家卫生系统的角度比较高血压患者中单片复方培哚普利/氨氯地平/吲达帕胺与自由等效联合用药的成本效益分析
Pierre Levy,Tobiasz Lemański,Catriona Crossan et al.
Pierre Levy et al.
Objective: To evaluate the cost-effectiveness of a single-pill combination (SPC) of perindopril/amlodipine/indapamide versus its free equivalent combination (FEC) in adults with hypertension in Italy. ...
Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves [0.03%]
后线治疗转移性结直肠癌的疗效比较：生存曲线网络meta分析
Mavis Obeng-Kusi,Jennifer R Martin,Denise Roe et al.
Mavis Obeng-Kusi et al.
Introduction: We evaluated the comparative efficacy of 6 later-line (≥3) therapies for metastatic colorectal cancer (mCRC) over placebo. We applied a novel statistical method of reconstructing pseudo patient-level data (...
Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve [0.03%]
高血压试验中的医患依从性：一个亟待解决的重要问题的观点透视
Michel Burnier
Michel Burnier
Introduction: Randomized controlled trials (RCTs) are important sources of evidence that strongly influence guidelines for patient management, including for elevated blood pressure in adults. ...